BioMarin Pharmaceuticals
BMRN
BMRN
529 hedge funds and large institutions have $13.5B invested in BioMarin Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 180 increasing their positions, 186 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $16.1B → $13.5B (-$2.65B)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
33% less call options, than puts
Call options by funds: $129M | Put options by funds: $192M
Holders
529
Holding in Top 10
5
Calls
$129M
Puts
$192M
Top Buyers
| 1 | +$168M | |
| 2 | +$153M | |
| 3 | +$95.2M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$60.8M |
| 5 |
MNG
Manning & Napier Group
Fairport,
New York
|
+$50.8M |
Top Sellers
| 1 | -$111M | |
| 2 | -$87.1M | |
| 3 | -$83.2M | |
| 4 |
BlackRock
New York
|
-$63.7M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$56.6M |